Categories : Oncology
Product Packaging : Single Vial
Product Composition : 3750 IU/5ml
Send MessagePEG L-Asparaginase Injection is a pegylated enzyme-based anticancer medication used primarily in the treatment of acute lymphoblastic leukemia (ALL). The medicine works by depleting asparagine, an amino acid essential for the survival and growth of leukemia cells, thereby inhibiting their proliferation. Genliva Wellness LLP is a trusted PEG L-Asparaginase Injection Manufacturer in India offering high-quality oncology formulations for domestic and international pharmaceutical markets.
This injectable formulation is widely used as a component of combination chemotherapy protocols for pediatric and adult leukemia treatment. As a reliable PEG L-Asparaginase Injection Exporter from India, Genliva Wellness LLP supplies quality-assured oncology products to healthcare institutions and pharmaceutical distributors worldwide.
PEG L-Asparaginase provides prolonged enzymatic activity compared to conventional L-Asparaginase and plays an important role in achieving effective leukemia treatment outcomes.
PEG L-Asparaginase Injection is formulated to provide sustained enzymatic anticancer activity in hematological malignancies.
PEG L-Asparaginase Injection is used in the treatment and management of specific hematological cancers.
PEG L-Asparaginase Injection provides sustained therapeutic activity for effective leukemia management.
